A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
Topic
R&D (2)
The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
The Fight Continues: Battling the COVID Evolution
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
A Ready-Made Solution for Accelerating RSV Research
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
Lessons Learned from COVID-19 Clinical Trials
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Four Steps to Linking Clinical Trial and Real-World Data
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Four Ways Lab Data Can Enhance Clinical Research
A recent survey by the Deloitte Center for Health Solutions of biopharma executives and other...
Advancing Diverse Representation in Clinical Trials and Research
HealthVerity offerings support the call for action by the Committee on Improving Representation of...
Celebrating Clinical Trials Day 2022
HealthVerity is pleased to celebrate Clinical Trials Day and all of the employees, volunteers, and...
HealthVerity IPGE changes the world for researchers
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...